Graham, David Y.
Article History
First Online: 20 September 2018
Compliance with ethical standards
:
: Dr. Graham is a consultant for RedHill Biopharma regarding novel <i>H. pylori</i> therapies. He has also received research support for culture of <i>Helicobacter pylori</i> and is the PI of an international study of the use of antimycobacterial therapy for Crohn’s disease. He is also a consultant for BioGaia in relation to probiotic therapy for <i>H. pylori</i> infection and for Takeda in relation to <i>H. pylori</i> therapies.